Tumour cells treated with only CA or US+CA did not show induced translocation of calreticulin or Erp57, or release of HMGB1 or ATP in vitro. There was no substantial difference in CD80+CD86+ cells (mature DCs) or IFN-γ-secreting cells in vivo between the two groups. This evidence concerns the gene CD86 and neoplasm.